Amicus Therapeutics
FOLD
#3908
Rank
โ‚น274.40 B
Marketcap
โ‚น889.38
Share price
-0.50%
Change (1 day)
7.61%
Change (1 year)

Earnings for Amicus Therapeutics (FOLD)

Earnings in 2025 (TTM): โ‚น0.53 Billion

According to Amicus Therapeutics 's latest financial reports the company's current earnings are โ‚น0.59 Billion. In 2024 the company made an earning of -โ‚น2.59 Billion, an increase over its 2023 earnings that were of -โ‚น13.49 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Amicus Therapeutics from 2007 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น0.53 B-120.87%
2024 -โ‚น2.59 Billion-80.84%
2023 -โ‚น13.49 Billion-37.98%
2022 -โ‚น21.75 Billion0.2%
2021 -โ‚น21.71 Billion-11.92%
2020 -โ‚น24.64 Billion-22.94%
2019 -โ‚น31.98 Billion1.95%
2018 -โ‚น31.37 Billion-22.27%
2017 -โ‚น40.35 Billion120.39%
2016 -โ‚น18.31 Billion54.24%
2015 -โ‚น11.87 Billion88.63%
2014 -โ‚น6.3 Billion10.92%
2013 -โ‚น5.68 Billion21.36%
2012 -โ‚น4.68 Billion8.3%
2011 -โ‚น4.32 Billion-14.33%
2010 -โ‚น5.04 Billion753.76%
2009 -โ‚น0.6 Billion-83.31%
2008 -โ‚น3.54 Billion-4.4%
2007 -โ‚น3.7 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
โ‚น171.04 B 38,117.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น61.02 B 13,534.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น2.47 Billion-650.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น837.53 B 187,031.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
-โ‚น6.17 Billion-1,476.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚น1.872 T 418,322.32%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark